乳制品组合物
By culturing mammary gland cell constructs in a bioreactor, dairy products containing specific proteins, lipids, and oligosaccharide components can be prepared. This solves the problem that traditional methods cannot replicate the molecular profile of dairy products, and provides a safe and sustainable dairy product solution to meet human nutritional needs.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BIOMILQ INC
- Filing Date
- 2021-05-26
- Publication Date
- 2026-07-17
AI Technical Summary
Existing technologies cannot effectively replicate the complete molecular profile of milk or dairy products, and breastfeeding has a significant impact on the mother's physiology and environment. Traditional fermentation methods rely on genetically engineered expression and purification, which cannot meet human nutritional needs.
By culturing mammary cell constructs in a bioreactor, including a three-dimensional scaffold, matrix material, and a polarized mammary cell monolayer, human breast milk produced by lactating women is simulated to prepare dairy products containing specific protein, lipid, and oligosaccharide components, avoiding harmful substances and meeting human nutritional needs.
This technology enables the in vitro production of dairy products that closely resemble human breast milk from mammary gland cells, meeting the nutritional needs of infants and immunocompromised individuals. It avoids the environmental and health challenges of traditional methods and provides a safe and sustainable dairy product solution.
Smart Images
Figure CN115698252B_ABST